<DOC>
	<DOCNO>NCT02973529</DOCNO>
	<brief_summary>Coronary artery disease often treat implantation permanent metallic stents.Coronary stent require early healing phase balloon dilatation constitute lifelong foreign body . New bioresorbable stent develop believe improve long-term safety . The purpose study compare safety vessel heal treatment simple bifurcation lesion CE-marked bioresorbable stent Absorb Desolve .</brief_summary>
	<brief_title>The Bioresorbable Implants Scaffolding Obstructions Randomized Bifurcations ( BIFSORB ) Study</brief_title>
	<detailed_description>BIFSORB prospective , randomized multicenter trial compare 6-month heal outcome treatment simple coronary bifurcation lesion Absorb Desolve BRS . treatment coronary bifurcation lesion . BRS promise treatment coronary artery disease . The concept bifurcation treatment use BRS particular appeal strut cover side branch ostium may resorb time . The aim study compare 6 month safety vessel heal treatment coronary bifurcation lesion Desolve Absorb BRS . Hypothesis : Treatment coronary bifurcation lesion use Absorb Desolve bioresorbable stent safe . Treatment coronary bifurcation lesion Desolve BRS associate low index adverse vessel wall feature ( main vessel area stenosis , acquire malapposition , evaginations , late recoil , single end attach protrude strut , side branch ostial area stenosis ) 6 month compare treatment Absorb BRS . Methods : Prospective , open label , single blind , randomize , feasibility safety pilot study inclusion 120 patient . Randomization 1:1 Absorb Desolve . Planned 6- 24-month follow-up OCT follow-up clinical endpoint 10 year . Eligible patient bifurcation lesion treat provisional technique mandatory jailing side branch provisional opening side branch ostium mini-kiss technique case severe pinch TIMI-flow le III . Proximal post-dilatation mandatory . No dilatation beyond expansion limit BRS . The patient assess optical coherence tomography ( OCT ) , implantation Absorb Desolve BRS baseline procedure 6- 24-month follow-up , readmitted possible target lesion failure . The operator blind pre-PCI OCT image may use size position scaffold . Procedural OCT may use optimize scaffold implantation perform final OCT . Results report clinical safety 6 month ( myocardial infarction , revascularization , death ) stent heal index OCT include malapposition , stent coverage , side branch ostial area late loss , fracture evaginations .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Stable angina pectoris Age &gt; 18 year Stabilized nonST elevation myocardial infarction Silent angina De novo coronary bifurcation lesion LAD/diagonal , CX/obtuse marginal , RCAPDA/posterolateral branch All Medina class except Medina x.x.1 Diameter side branch ≥ 2.5 mm Signed informed consent STelevation infarction within 48 hour Expected survival &lt; 1 year Severe heart failure ( NYHA≥III ) Screatinine &gt; 120 µmol/L Allergy contrast medium , aspirin , clopidogrel , ticagrelor , ticlopidine , everolimus novolimus Unable cover main vessel lesion one scaffold Severe tortuosity Severe calcification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Percutaneous intervention ( PCI )</keyword>
	<keyword>Optical coherence tomography ( OCT )</keyword>
	<keyword>Bifurcation lesion</keyword>
	<keyword>Bioresorbable stent ( BRS )</keyword>
</DOC>